Results 291 to 300 of about 25,999 (347)

Rapid disease progression and hydrocephalus following tarlatamab therapy initiation: A case report. [PDF]

open access: yesRespir Med Case Rep
Fukui D   +9 more
europepmc   +1 more source

DIPHENYLHYDANTOIN (DILANTIN) NEUROTOXICITY—A DECEPTIVE SYNDROME

Journal of the American Geriatrics Society, 1969
A bstract Two patients are reported in whom diphenylhydantoin (Dilantin) neurotoxicity developed as a result of inadvertent overdosage. The clinical features indicative of such toxicity are emphasized.
M K, Ang, R, Guiang, A R, Berger
openaire   +2 more sources

Vincristine neurotoxicity in Charcot‐Marie‐Tooth syndrome

Medical Journal of Australia, 1985
The case of a patient with Charcot-Marie-Tooth syndrome and diffuse large-cell lymphoma, in whom a severe generalized weakness developed after the intravenous administration of vincristine (2 mg) during combination chemotherapy, is reported. Spontaneous resolution of the severe weakness occurred when teniposide was substituted for vincristine in the ...
J D, Griffiths   +3 more
openaire   +2 more sources

Neurotoxic Weapons and Syndromes

2016
The modern era of chemical and biological warfare began in World War I with the large-scale production and use of blistering and choking agents (chlorine, phosgene and mustard gases) in the battlefield. International treaties (the 1925 Geneva Protocol, the 1975 Biological and Toxin Weapons Convention and the 1993 Chemical Weapons Convention) banned ...
Antonio Carota   +2 more
openaire   +2 more sources

p,p'‐DDT‐induced neurotoxic syndrome

Neurology, 1978
p,p'-DDT (100 to 600 mg per kilogram orally) produced spontaneous and stimulus-sensitive myoclonus in mice and rats. Drugs that enhance brain serotonergic activity reduced p,p'-DDT-induced myoclonus, and serotonin antagonists invariably aggravated this syndrome.
E C, Hwang, M H, Van Woert
openaire   +2 more sources

Home - About - Disclaimer - Privacy